Showing results (1031-1040 of 1,398) with videos related to
Sort By:
Pageof 140
Drug Development Research|January 25, 2021
Alpha-lipoic acid: A promising adjuvant for nonsteroidal anti-inflammatory drugs therapy with improved efficacy and gastroprotectionElif Nur Barut, Seçkin Engin, İsmail Saygın, et al.Drug Development Research|February 3, 2021
Anatomical distribution and expression of CYP in humans: Neuropharmacological implicationsDaniela Fanni, Federica Pinna, Clara Gerosa, et al.Drug Development Research|January 18, 2022
An overview of sulfonamide-based conjugates: Recent advances for tuberculosis treatmentCauê Benito Scarim, Fernando Rogério PavanDrug Development Research|January 4, 2022
CircRNF121 knockdown suppresses the progression of cervical cancer by regulating miR-153-3p/ATF2 axis and wnt/β-catenin pathwayQi Wang, Bai Xu, Haiping Liu, et al.Drug Development Research|February 15, 2019
Ilexgenin A inhibits mitochondrial fission and promote Drp1 degradation by Nrf2-induced PSMB5 in endothelial cellsYingchao Zhu, Ming Li, Yawen Lu, et al.Drug Development Research|May 17, 2011
Discovering Molecular Targets in Cancer with Multiscale ModelingZhihui Wang, Veronika Bordas, Thomas S DeisboeckDrug Development Research|May 14, 2011
A Discovery Funnel for Nucleic Acid Binding Drug CandidatesPatrick A Holt, Robert Buscaglia, John O Trent, et al.Drug Development Research|January 14, 2012
The Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for ImmunosuppressionJenny Lam, Heike WulffDrug Development Research|February 1, 2022
Estradiol reduces ACE2 and TMPRSS2 mRNA levels in A549 human lung epithelial cellsGabriele Baristaite, David GurwitzDrug Development Research|October 17, 2019
A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressantsSofia H Kanders, Claudia Pisanu, Marcus Bandstein, et al.Pageof 140